Paper Details

  1. Home
  2. Paper Details

New pharmacological treatments for the management of obesity.

Author: EbbertJon O, Edakkanambeth VarayilJithinraj, HurtRyan T

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This article reviews the pharmacology, clinical efficacy, and safety of two new medications for obesity, lorcaserin and phentermine/topiramate extended release (ER), in comparison to older and current medications. The authors highlight the challenges in developing effective and safe medications for obesity.
Paper Details　
Original Abstract of the Article :
Obesity is quickly becoming the leading preventable cause of death in the USA. Over 60 obesity-related comorbidities exist which increase the complexity and cost of medical care in obese patients. Even a moderate weight loss of 5 % can reduce morbidity associated with these conditions. Lifestyle mod...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s11894-014-0394-0

データ提供：米国国立医学図書館（NLM）

New Medications: A Ray of Hope in the Desert of Obesity

The world of obesity is a vast and complex desert, with many challenges to overcome. This review explores the latest advancements in pharmacologic treatment for obesity, focusing on two newly approved medications: lorcaserin and phentermine/topiramate extended release (ER). The authors delve into the pharmacology, clinical efficacy, and safety of these medications, comparing them to previous and current options.

A New Oasis for Obesity Management

This review highlights the emergence of new pharmacologic options for managing obesity. Lorcaserin and phentermine/topiramate ER offer promising alternatives to existing treatments, potentially providing a more effective and well-tolerated approach for weight loss. This is like finding a new oasis in the desert, providing a source of hope and potentially leading to better health outcomes for individuals struggling with obesity.

Navigating the Desert of Obesity

This review provides a valuable overview of the evolving landscape of pharmacologic treatment for obesity. The emergence of new medications like lorcaserin and phentermine/topiramate ER offers a potentially more effective and safe path to weight management. This is a journey through the desert of obesity, and this review offers a valuable guide to the latest advancements in treatment.

Dr.Camel's Conclusion

This review showcases the emergence of new medications for managing obesity. Lorcaserin and phentermine/topiramate ER offer promising alternatives to existing treatments, potentially providing a more effective and well-tolerated approach for weight loss. It's like finding a new oasis in the desert, offering hope for a brighter future and a more sustainable path to health for individuals struggling with obesity.

Date :
  1. Date Completed 2014-12-29
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

24828101

DOI: Digital Object Identifier

10.1007/s11894-014-0394-0

Related Literature

Article Analysis
・Side Effects of phentermine and topiramate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.